Thursday, January 31, 2013
Publication and contact
Free fatty acid receptor 1 (FFAR1;
In vitro and mouse studies identified an alkyne series of
FFAR1 agonists that could help treat type 2
diabetes. In healthy mice, an alkyne-based FFAR1 agonist with polar
substituents on the terminal phenyl ring was orally bioavailable and
increased glucose tolerance at least as much as the marketed type 2 diabetes
Next steps include testing the compounds in rodent models of diabetes.
Life Sciences Pvt. Ltd. has FFAR1 agonists including CNX-011-67
in preclinical testing to treat diabetes.
Pharmaceutical Co. Ltd.'s FFAR1 agonist, TAK-875,
is in Phase III testing for the indication.
& Co. Inc. and Ono
Pharmaceutical Co. Ltd. market the dipeptidyl
inhibitor Glactiv sitagliptin to treat diabetes.
SciBX 6(4); doi:10.1038/scibx.2013.87
Published online Jan. 31, 2013
Patent application filed
covering compounds; available for licensing
Christiansen, E. et al.
J. Med. Chem.; published online Jan. 8, 2013;
Contact: Trond Ulven, University of Southern Denmark,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]